A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

NCT00561366 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Not moving forward with program.

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Placebo
DRUG: Arimoclomol

Sponsor

CytRx